October 10, 2024
UC San Diego has received a $7 million ARPA-H contract for the PROTECT project, targeting pathogens like Pseudomonas aeruginosa and Staphylococcus aureus. These pathogens pose serious health risks to individuals with cystic fibrosis and those reliant on respirators.
November 23, 2020
While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with an increased tendency of the blood to clot, leading to a higher risk of death from COVID-19.
May 2, 2024
Stephanie Fraley, Marygorret Obonyo and Daniela Valdez-Jasso have been named Prebys Research Heroes. Grants totaling $1.5 million from the Prebys Foundation will support their research focused on advancing health care and medical discoveries.
July 3, 2024
…cells into cancer tumors also shuttles inflammatory cells into lung tissue infected with COVID-19 — and that the molecule can be suppressed with a repurposed cancer drug. The work represents a new approach to preventing irreversible organ damage in infectious diseases.
September 15, 2020
UC San Diego researchers discovered that the SARS-CoV-2 virus can’t grab hold of cell receptor ACE2 without a carbohydrate called heparan sulfate, which is also found on lung cell surfaces — disrupting that interaction with a repurposed drug may help treat COVID-19.
August 27, 2019
For the first time in Southern California, surgeons at UC San Diego Health have transplanted the kidney of a deceased donor with HIV into a recipient with a pre-existing HIV infection. The procedure is part of an unprecedented multi-site national clinical trial.
September 17, 2020
…second crush of COVID-19 infections. But because the novel coronavirus is, well, novel, no one can yet say if that will happen. One thing is certain, though, another viral wave is coming: flu season. Influenza season occurs during the cold half of the year in each hemisphere. In the United…
April 12, 2022
UC San Diego study shows chronic JUUL use leads to inflammatory changes across the body, and may affect organs’ response to infection; results depend on e-cigarette flavor.
April 30, 2020
UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.
April 14, 2020
Researchers suggest that in the aftermath of the novel coronavirus pandemic, a host of neuropsychiatric challenges may remain — or emerge — for those recovering from COVID-19 infections.
